Rare diseases
Investigational molecules
Locations
Study of blinatumomab plus drug combination in children and adolescents with acute lymphoblastic leukemia
GermanyDalbavancin versus standard drug combination for treatment of infective endocarditis caused by Gram‑positive cocci in adult patients
GermanyEfficacy of asciminib in chronic phase chronic myeloid leukemia patients with T315I mutation
GermanyShortening treatment duration in adults with uncomplicated candidemia: caspofungin acetate versus saline and sodium lactate placebo
GermanyBMS-986365 in Metastatic Castration-Sensitive Prostate Cancer in Patients with Suboptimal PSA Response After ADT and ARPI
GermanyAngiotensin II in Children and Adolescents With Refractory Hypotension in Distributive Shock
GermanyA study to evaluate the safety and effectiveness of subcutaneous blinatumomab in adults and adolescents with relapsed, refractory, or minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.
GermanyStudy comparing CHF 5993 (beclometasone/formoterol/glycopyrronium) to fluticasone/salmeterol inhalation in adolescents with uncontrolled asthma on medium-dose inhaled therapy
GermanyStudy of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety
GermanyStudy on the Effectiveness and Safety of Masitinib and Riluzole for Patients with Amyotrophic Lateral Sclerosis (ALS)
GermanyStudy of Loncastuximab Tesirine and Epcoritamab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma, High-grade B-cell Lymphoma, or Follicular Lymphoma Grade 3B
GermanyStudy on the Safety and Effectiveness of Trastuzumab Deruxtecan with Drug Combination for Patients with HER2+ Resectable Esophagogastric Cancer
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
